Abstract：Objective: To explore clinical application, safety and exactitude of C-arm CT-guided percutaneous lung biopsy in the diagnosis of chest tumor. Methods: The clinical data of 243 cases with C-arm CT-guided percutaneous lung biopsy from February to December 2018 were analyzed respectively. Including technical success rate, accuracy, sensibility, specificity, and the incidence of complications. Results: A total of 249 percutaneous biopsies were performed in 243 cases, 6 cases biopsies were performed for two times, and the technical success was 100%, the incidence of complications was 12.7%. 48 cases accepted surgical operation. Totally diagnostic accuracy was 97.92%(47/48), sensibility was 97.73%(43/44), specificity was 100%(4/4). Conclusion: C-arm CT combines advantages DSA and CT imaging techniques, optimizing the flow of lung biopsy, it has obvious advantages in percutaneous lung biopsy, and has the technical characteristics such as high accuracy and fewer the incidence of complications. C-arm CT-guided percutaneous lung biopsy is safe and reliable. It is worthy of application and promotion.
樊庆勇，郑 旭，季 芳，葛莉萍，郝俊山，牛德方. C臂CT引导胸部肿瘤经皮穿刺活检的临床价值分析[J]. 中国临床医学影像杂志, 2020, 31(6): 410-413.
FAN Qing-yong, ZHENG Xu, JI Fang, GE Li-ping, HAO Jun-shan, NIU De-fang. Clinical value of C-arm CT-guided percutaneous lung biopsy. JOURNAL OF CHINA MEDICAL IMAGING, 2020, 31(6): 410-413.
